ApoA-I and Cancer
High-density lipoprotein (HDL) and apolipoprotein A-I (apoA-I), the predominant protein in plasma HDL, have long been the focus of intense studies in the field of atherosclerosis and cardiovascular disease (CVD). ApoA-I, in large part, is responsible for HDL assembly and its main atheroprotective fu...
| Main Authors: | , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Frontiers Media S.A.
2015-11-01
|
| 丛编: | Frontiers in Pharmacology |
| 主题: | |
| 在线阅读: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00265/full |